AZN » Topics » not adopted

This excerpt taken from the AZN 20-F filed Mar 27, 2007.
not adopted
IFRS 7 ‘Financial Instruments: Disclosures’ was issued in August 2005. It revises and enhances previous disclosures required by IAS 32 ‘Financial Instruments: Disclosure and Presentation’ and IAS 30 ‘Disclosures in the Financial Statements of Banks and similar Financial Institutions’. It is effective for annual periods beginning on or after 1 January 2007. The adoption of IFRS 7 will have no impact upon the results or net assets of AstraZeneca.

IFRS 8 ‘Operating Segments’ was issued in November 2006. It requires the identification of operating segments based on internal reporting to the chief operating decision maker and extends the scope and disclosure requirements of IAS 14 ‘Segmental Reporting’. It is effective for annual periods beginning on or after 1 January 2009. The adoption of IFRS 8 will have no impact upon the net results or net assets of AstraZeneca.


 


Back to Contents

104 ASTRAZENECA ANNUAL REPORT AND FORM 20-F INFORMATION 2006
This excerpt taken from the AZN 6-K filed Mar 6, 2007.
not adopted
IFRS 7 ‘Financial Instruments: Disclosures’ was issued in August 2005. It revises and enhances previous disclosures required by IAS 32 ‘Financial Instruments: Disclosure and Presentation’ and IAS 30 ‘Disclosures in the Financial Statements of Banks and similar Financial Institutions’. It is effective for annual periods beginning on or after 1 January 2007. The adoption of IFRS 7 will have no impact upon the results or net assets of AstraZeneca.

IFRS 8 ‘Operating Segments’ was issued in November 2006. It requires the identification of operating segments based on internal reporting to the chief operating decision maker and extends the scope and disclosure requirements of IAS 14 ‘Segmental Reporting’. It is effective for annual periods beginning on or after 1 January 2009. The adoption of IFRS 8 will have no impact upon the net results or net assets of AstraZeneca.


 


Back to Contents

104 ASTRAZENECA ANNUAL REPORT AND FORM 20-F INFORMATION 2006

EXCERPTS ON THIS PAGE:

20-F
Mar 27, 2007
6-K
Mar 6, 2007
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki